Month: May 2017
OP/ED: How 23andMe Will Affect Your Medical Practice
On April 30, 2017, the Wall Street Journal published a column, Personalized Medicine is Here, on the Food and Drug Administration’s recent approval of 10 screening tests for the company 23andMe. The authors Peter Huber and Paul Howard, who are senior fellows at the Manhattan Institute, write: “We applaud theRead
Unique Probiotic Strain May Reduce Depression in IBS Patients
The role of probiotics for gastrointestinal conditions is well known, however a new study shows a specific strain of probiotics may also relieve symptoms of depression, according to research from McMaster University and published in the journal Gastroenterology (May 2, 2017). Researchers say this study offers further evidence of howRead
Promising Study on Selenium and CoQ10 for Cardio Health and Reduced Inflammation
In an epidemiological study in a rural municipality in Sweden that started in 1998, all participants in the age between 70–80 were invited to participate in the intervention study with selenium and coenzyme Q10. 443 accepted participation in the study. The study is an evaluated changes in expression of microRNAs asRead
Naturopathic Science Review on Anxiety Treatments
A Stress in America study (2015) revealed that a significant number of Americans are under a great deal of stress. Money and work top out as the primary source of stress, with family responsibilities following close behind. It’s not surprisingly that “two in five adults (39 percent) report overeating or
Why the New York Times Got It Wrong about Vitamin D
Recently, a New York Times (NYT) article, Why are So Many People Popping Vitamin D?, suggested that taking vitamin D is a waste of time and money. Gina Kolata, a medical journalist for the NYT, highlighted two new studies concluding that vitamin D does not prevent cardiovascular disease (CVD) orRead